Ionis Pharmaceuticals

E24882
biotechnology company pharmaceutical company public company

Ionis Pharmaceuticals is a biotechnology company specializing in the discovery and development of RNA-targeted therapeutics using antisense technology.

Try in SPARQL Jump to: Surface forms Statements Referenced by

All labels observed (6)

Label Occurrences
Ionis Pharmaceuticals canonical 8
Ionis Pharmaceuticals, Inc. 2
Akcea Therapeutics (historical affiliate) 1

Statements (47)

Predicate Object
instanceOf biotechnology company ⓘ
pharmaceutical company ⓘ
public company ⓘ
aimsTo treat diseases by targeting RNA ⓘ
basedIn California, United States ⓘ
surface form: California
coDeveloped Spinraza ⓘ
coDevelopedWith Biogen ⓘ
country United States of America ⓘ
surface form: United States
develops antisense oligonucleotide drugs ⓘ
focusesOn cardiovascular diseases ⓘ
metabolic diseases ⓘ
neurological diseases ⓘ
rare diseases ⓘ
formerName Ionis Pharmaceuticals self-linksurface differs ⓘ
surface form: Isis Pharmaceuticals
foundedBy Stanley T. Crooke ⓘ
foundingYear 1989 ⓘ
hasCollaborationWith AstraZeneca ⓘ
Bayer ⓘ
Biogen ⓘ
GlaxoSmithKline ⓘ
surface form: GSK

Novartis ⓘ
Pfizer ⓘ
Roche ⓘ
hasSubsidiaryOrAffiliate Ionis Pharmaceuticals self-linksurface differs ⓘ
surface form: Akcea Therapeutics (historical affiliate)
headquartersLocation Carlsbad ⓘ
surface form: Carlsbad, California, United States
industry biotechnology ⓘ
pharmaceuticals ⓘ
listedOn Nasdaq Biotechnology Index ⓘ
surface form: NASDAQ-100 Biotechnology Index
notableProduct Spinraza ⓘ
Tegsedi ⓘ
Waylivra ⓘ
primaryBusinessModel drug discovery and development ⓘ
regionServed global ⓘ
researchArea cardiometabolic diseases ⓘ
genetic diseases ⓘ
neurodegenerative diseases ⓘ
revenueSource collaboration payments ⓘ
licensing revenue ⓘ
product sales ⓘ
specializesIn RNA-targeted therapeutics ⓘ
antisense technology ⓘ
stockExchange NASDAQ ⓘ
technologyPlatform antisense oligonucleotide platform ⓘ
therapeuticApproach RNA-targeted drug discovery ⓘ
tickerSymbol IONS ⓘ
uses antisense oligonucleotides to modulate RNA ⓘ
website https://www.ionispharma.com ⓘ

Referenced by (14)

Full triples — surface form annotated when it differs from this entity's canonical label.

Biogen → collaboratesWith → Ionis Pharmaceuticals ⓘ
Spinraza → developedBy → Ionis Pharmaceuticals ⓘ
Ionis Pharmaceuticals → formerName → Ionis Pharmaceuticals self-linksurface differs ⓘ
this entity surface form: Isis Pharmaceuticals
Ionis Pharmaceuticals → hasSubsidiaryOrAffiliate → Ionis Pharmaceuticals self-linksurface differs ⓘ
this entity surface form: Akcea Therapeutics (historical affiliate)
IONS → represents → Ionis Pharmaceuticals ⓘ
this entity surface form: Ionis Pharmaceuticals, Inc.
IONS → formerName → Ionis Pharmaceuticals ⓘ
subject surface form: Ionis Pharmaceuticals, Inc.
this entity surface form: Isis Pharmaceuticals, Inc.
IONS → issuer → Ionis Pharmaceuticals ⓘ
this entity surface form: Ionis Pharmaceuticals, Inc.
Tegsedi → developedBy → Ionis Pharmaceuticals ⓘ
Tegsedi → belongsTo → Ionis Pharmaceuticals ⓘ
this entity surface form: Ionis antisense pipeline
Waylivra → marketingAuthorisationHolder → Ionis Pharmaceuticals ⓘ
Waylivra → developedBy → Ionis Pharmaceuticals ⓘ
Stanley T. Crooke → employer → Ionis Pharmaceuticals ⓘ
Stanley T. Crooke → founded → Ionis Pharmaceuticals ⓘ
Stanley T. Crooke → hasLeadershipRoleIn → Ionis Pharmaceuticals ⓘ